Beijing Lu de Kai Qi Co., Ltd.

China

Back to Profile

1-3 of 3 for Beijing Lu de Kai Qi Co., Ltd. Sort by
Query
Aggregations
IPC Class
A61K 36/282 - Artemisia, e.g. wormwood or sagebrush 3
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate 3
A61K 36/52 - Juglandaceae (Walnut family) 2
A61K 35/60 - Fish, e.g. seahorsesFish eggs 1
A61K 36/258 - Panax (ginseng) 1
See more
Found results for  patents

1.

PHARMACEUTICAL PRODUCT FOR TREATING LUPUS ERYTHEMATOSUS AND COMBINED IMMUNE DEFECT, AND PREPARATION AND APPLICATION THEREOF

      
Application Number CN2016078649
Publication Number 2017/173609
Status In Force
Filing Date 2016-04-07
Publication Date 2017-10-12
Owner BEIJING LU DE KAI QI CO., LTD. (China)
Inventor Lu, Wei

Abstract

A pharmaceutical product for treating lupus erythematosus and for enhancing immunity. The product comprises the following raw materials (in parts by weight): a Juglans regia extract (1), Blumea balsamifera extract (0.5-2), Panax quinquefolius extract (1-5), and Dendrobium nobile extract (1-10). The pharmaceutical product is prepared using a supercritical fluid extraction process and a spray drying process. The pharmaceutical product can enhance immunity and can prevent or treat lupus erythematosus.

IPC Classes  ?

2.

PHARMACEUTICAL PRODUCT FOR TREATING ANKYLOSING SPONDYLITIS AND COMBINED IMMUNE DEFECT, AND PREPARATION AND APPLICATION THEREOF

      
Application Number CN2016078650
Publication Number 2017/173610
Status In Force
Filing Date 2016-04-07
Publication Date 2017-10-12
Owner BEIJING LU DE KAI QI CO., LTD. (China)
Inventor Lu, Wei

Abstract

A pharmaceutical product for treating ankylosing spondylitis and combined immune defect. Raw materials of the pharmaceutical product comprises a Rosa roxbunghii extract, a Blumea balsamifera extract, a seahorse extract, and a Corydalis yanhusuo extract respectively provided in a weight ratio of (1-10):(0.5-2):1:(1-10). The pharmaceutical product is prepared using a supercritical fluid extraction process, facilitating in vivo dissolution and human body absorption.

IPC Classes  ?

  • A61K 36/738 - Rosa (rose)
  • A61K 36/66 - Papaveraceae (Poppy family), e.g. bloodroot
  • A61K 36/282 - Artemisia, e.g. wormwood or sagebrush
  • A61K 35/60 - Fish, e.g. seahorsesFish eggs
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
  • A61P 37/04 - Immunostimulants

3.

PHARMACEUTICAL PRODUCT FOR TREATING TUMOR AND COMBINED IMMUNE DEFECT, AND PREPARATION AND APPLICATION THEREOF

      
Application Number CN2016078651
Publication Number 2017/173611
Status In Force
Filing Date 2016-04-07
Publication Date 2017-10-12
Owner BEIJING LU DE KAI QI CO., LTD. (China)
Inventor Lu, Wei

Abstract

A pharmaceutical composition for treating a tumor and combined immune defect. The composition comprises a Juglans regia extract, a Blumea balsamifera extract, and a Syzygium aromaticum extract provided in a weight ratio of 77:54:98. The composition can suppress microbial growth and exerts anti-microbial effects, enhance the immunity of an organism, provides stronger anticancer activity, and can prevent tumor recurrence. The composition is prepared using a supercritical fluid extraction process.

IPC Classes  ?

  • A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
  • A61K 36/52 - Juglandaceae (Walnut family)
  • A61K 36/282 - Artemisia, e.g. wormwood or sagebrush
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61P 35/00 - Antineoplastic agents